Association Between Inpatient Medication Treatment for Opioid Use Disorder and Reduced One-Year All-Cause Mortality in Patients With Invasive Bacterial Infections - Scorecard - MDSpire

Association Between Inpatient Medication Treatment for Opioid Use Disorder and Reduced One-Year All-Cause Mortality in Patients With Invasive Bacterial Infections

  • By

  • Nicholas J Blair

  • Adam Kopp

  • Christine Kubin

  • Jesse Cotton

  • Michael T Yin

  • Matthew Scherer

  • February 3, 2025

  • 0 min

Share

Clinical Scorecard: Link Between In-Hospital Opioid Use Disorder Treatment and Decreased One-Year All-Cause Mortality in Patients With Invasive Bacterial Infections

At a Glance

CategoryDetail
ConditionInvasive bacterial infections in patients with opioid use disorder (OUD)
Key MechanismsInpatient administration of medications for opioid use disorder (MOUD) including buprenorphine, methadone, or naltrexone
Target PopulationAdults aged 18–65 years with recent opioid use hospitalized with invasive bacterial infections
Care SettingInpatient hospital setting during treatment for invasive bacterial infections

Key Highlights

  • Invasive bacterial infections such as endocarditis are common and highly morbid complications among people with OUD.
  • Administration of MOUD during hospitalization is associated with decreased one-year all-cause mortality in this population.
  • Hospitalization presents a critical opportunity to initiate MOUD and link patients to outpatient care, though linkage rates remain low.

Guideline-Based Recommendations

Diagnosis

  • Use updated 2023 Duke criteria to diagnose endocarditis in patients with invasive bacterial infections.
  • Confirm opioid use through chart review, urine toxicology, and patient report within the previous year.

Management

  • Administer MOUD (buprenorphine, methadone, or naltrexone) for at least 50% of hospital days to ensure therapeutic exposure.
  • Complete recommended antibiotic treatment duration (2 to 6 weeks of intravenous antibiotics) for invasive bacterial infections.
  • Engage psychiatry consult service for inpatient withdrawal management and MOUD initiation.

Monitoring & Follow-up

  • Follow patients for one year post-discharge to assess all-cause mortality and treatment adherence.
  • Monitor housing stability as it may impact treatment outcomes.

Risks

  • Low rates of linkage to outpatient MOUD after hospitalization may reduce long-term benefits.
  • Patients with unstable housing may face additional barriers to completing treatment.

Patient & Prescribing Data

Adults with recent opioid use hospitalized for invasive bacterial infections including endocarditis

Inpatient MOUD administration is associated with reduced one-year all-cause mortality; minimal or single-dose MOUD exposure is insufficient.

Clinical Best Practices

  • Identify patients with OUD early during hospitalization for invasive bacterial infections.
  • Initiate and maintain MOUD during hospital stay to improve survival outcomes.
  • Coordinate multidisciplinary care including infectious diseases and psychiatry teams.
  • Use prolonged intravenous antibiotic therapy as per Infectious Diseases Society of America guidelines.
  • Address social determinants such as housing instability to support treatment adherence.

References

Original Source(s)

Related Content